WebIndicated for prevention of cardiac complications in patients with unstable angina with PCI planned within 24 hr. 0.25 mg/kg IV bolus over at least 1 minute, THEN. 0.125 mcg/kg/min IV continiuous infusion for 18-24 hr concluding 1 hour post-PCI; not to exceed 10 mcg/min. Stop continuous infusion of abciximab in patients with failed PCIs. WebHeparin Resistance — Clinical Perspectives and Management Strategies. Drug resistance is defined as the lack of expected response to a standard therapeutic dose of a drug or as …

Intravenous Dabigatran Provides Adequate Anticoagulation for ...

Web14 apr. 2024 · To monitor bivalirudin therapy, APTT hepzyme (HPTT), intrinsic coagulation pathways with. heparinase (HEPTEM), and measurement of the clotting time … Web1 feb. 2024 · Since direct measurement of bivalirudin concentration or anti-IIa assay is not clinically available, aPTT, plasma diluted thrombin time, or ecarin chromogenic assay can be used to monitor bivalirudin therapy . When aPTT is used to monitor bivalirudin therapy, the goal is to achieve a prolongation of 1.5–2.5 times the baseline . bow attached blind

The Efficacy and Safety of Bivalirudin Versus Heparin in the ...

Web8 dec. 2024 · Neonates are born with low concentrations of AT, and critically ill children have AT levels that are 50% less than those of age-matched controls. 37 Monitoring of AT … Web1 feb. 2024 · Since direct measurement of bivalirudin concentration or anti-IIa assay is not clinically available, aPTT, plasma diluted thrombin time, or ecarin chromogenic assay … WebThe predominant indication of bivalirudin therapy was suspected pump thrombosis (13/17). The median time from VAD insertion to initiation of bivalirudin was 116 days (range, 3–1,870) with the median duration of therapy being 21 days (range, 3–113). In patients with pump thrombosis, the mean baseline lactate dehydrogenase (LDH) was 229 ± 64 ... guitarist dickey betts